British Journal of Dermatology logo Blackwell Publishing logo

Publisher: Blackwell Publishing

Volume 160, Number 3, March 2009
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Research Snippets
pp. i-ii(1)

In vivo confocal laser scanning microscopy in the diagnosis of melanocytic skin tumours
pp. 475-481(7)
Authors: Gerger, A.; Hofmann-Wellenhof, R.; Samonigg, H.; Smolle, J.

How not to get scar(r)ed: pointers to the correct diagnosis in patients with suspected primary cicatricial alopecia
pp. 482-501(20)
Authors: Harries, M.J.; Trueb, R.M.; Tosti, A.; Messenger, A.G.; Chaudhry, I.; Whiting, D.A.; Sinclair, R.; Griffiths, C.E.M.; Paus, R.

Blistering skin disorders: an evidence-based update. Conference report
pp. 502-504(3)
Authors: Alexandroff, A.B.; Harman, K.E.

The CYP26 inhibitor R115866 potentiates the effects of all-trans retinoic acid on cultured human epidermal keratinocytes
pp. 505-513(9)
Authors: Giltaire, S.; Herphelin, F.; Frankart, A.; Hérin, M.; Stoppie, P.; Poumay, Y.

Does tobacco smoking influence the occurrence of hand eczema?
pp. 514-518(5)
Authors: Meding, B.; Alderling, M.; Albin, M.; Brisman, J.; Wrangsjö, K.

Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma
pp. 519-526(8)
Authors: Nieto-Rementería, N.; Pérez-Yarza, G.; Boyano, M.D.; Apraiz, A.; Izu, R.; Díaz-Pérez, J.L.; Asumendi, A.

Pili annulati: refinement of the locus on chromosome 12q24.33 to a 2·9-Mb interval and candidate gene analysis
pp. 527-533(7)
Authors: Giehl, K.A.; Rogers, M.A.; Radivojkov, M.; Tosti, A.; de Berker, D.A.R.; Weinlich, G.; Schmuth, M.; Ruzicka, T.; Eckstein, G.N.

A clinical trial and molecular study of photoadaptation in vitiligo
pp. 534-539(6)
Authors: Hexsel, C.L.; Mahmoud, B.H.; Mitchell, D.; Rivard, J.; Owen, M.; Strickland, F.M.; Lim, H.W.; Hamzavi, I.

Asymmetrical transmission of human herpesvirus 8 among spouses of patients with Kaposi sarcoma
pp. 540-545(6)
Authors: Dupuy, A.; Schulz, T.; Chevret, S.; Agbalika, F.; Pellet, C.; Janier, M.; Dupin, N.; Vérola, O.; Calvo, F.; Lebbé, C.

FGFR3 and PIK3CA mutations are involved in the molecular pathogenesis of solar lentigo
pp. 546-551(6)
Authors: Hafner, C.; Stoehr, R.; van Oers, J.M.M.; Zwarthoff, E.C.; Hofstaedter, F.; Landthaler, M.; Hartmann, A.; Vogt, T.

Enhancement of bioavailability by lowering of fat content in topical formulations
pp. 552-556(5)
Authors: Wirén, K.; Frithiof, H.; Sjöqvist, C.; Lodén, M.

Care of patients with psoriasis: an audit of U.K. services in secondary care
pp. 557-564(8)
Authors: Eedy, D.J.; Griffiths, C.E.M.; Chalmers, R.J.G.; Ormerod, A.D.; Smith, C.H.; Barker, J.N.W.N.; Potter, J.; Ingham, J.; Lowe, D.; Burge, S.

Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data
pp. 573-580(8)
Authors: Lawrence, C.M.; Haniffa, M.; Dahl, M.G.C.

Altered expression of angiogenesis and lymphangiogenesis markers in the uninvolved skin of plaque-type psoriasis
pp. 581-590(10)
Authors: Henno, A.; Blacher, S.; Lambert, C.; Colige, A.; Seidel, L.; Noël, A.; Lapière, C.; de la Brassinne, M.; Nusgens, B.V.

Acral lentiginous melanoma: conventional histology vs. three-dimensional histology
pp. 591-599(9)
Authors: Lichte, V.; Breuninger, H.; Metzler, G.; Haefner, H.M.; Moehrle, M.

Cytoplasmic β-catenin is lacking in a subset of melanoma-associated naevi, but is detectable in naevus-associated melanomas: potential implications for melanoma tumorigenesis?
pp. 600-608(9)
Authors: De Panfilis, G.; Ferrari, D.; Santoro, S.; Ricci, R.; Lombardi, M.; Pedrazzi, G.; Pepe, C.; Cortelazzi, C.; Santini, M.

Stem cell markers (cytokeratin 15, CD34 and nestin) in primary scarring and nonscarring alopecia
pp. 609-615(7)
Authors: Hoang, M.P.; Keady, M.; Mahalingam, M.

Occupational skin exposure to water: a population-based study
pp. 616-621(6)
Authors: Anveden Berglind, I.; Alderling, M.; Järvholm, B.; Lidén, C.; Meding, B.

Prevalence and types of androgenetic alopecia in Shanghai, China: a community-based study
pp. 629-632(4)
Authors: Xu, F.; Sheng, Y-Y.; Mu, Z-L.; Lou, W.; Zhou, J.; Ren, Y-T.; Qi, S-S.; Wang, X-S.; Fu, Z-W.; Yang, Q-P.

Itch characteristics in atopic dermatitis: results of a web-based questionnaire
pp. 642-644(3)
Authors: Dawn, A.; Papoiu, A.D.P.; Chan, Y.H.; Rapp, S.R.; Rassette, N.; Yosipovitch, G.

Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome
pp. 645-651(7)
Authors: Halabi-Tawil, M.; Ruemmele, F.M.; Fraitag, S.; Rieux-Laucat, F.; Neven, B.; Brousse, N.; De Prost, Y.; Fischer, A.; Goulet, O.; Bodemer, C.

Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study
pp. 652-658(7)
Authors: Gambichler, T.; Othlinghaus, N.; Tomi, N.S.; Holland-Letz, T.; Boms, S.; Skrygan, M.; Altmeyer, P.; Kreuter, A.

Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome
pp. 670-675(6)
Authors: Driessen, R.J.B.; Boezeman, J.B.; van de Kerkhof, P.C.M.; de Jong, E.M.G.J.

Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: assessment of topical bioavailability
pp. 676-686(11)
Authors: Wiedersberg, S.; Naik, A.; Leopold, C.S.; Guy, R.H.

First experience with enteric-coated mycophenolate sodium (Myfortic®) in severe recalcitrant adult atopic dermatitis: an open label study
pp. 687-691(5)
Authors: van Velsen, S.G.A.; Haeck, I.M.; Bruijnzeel-Koomen, C.A.F.M.; de Bruin-Weller, M.S.

Novel truncating mutations in PKP1 and DSP cause similar skin phenotypes in two Brazilian families
pp. 692-697(6)
Authors: Tanaka, A.; Lai-Cheong, J.E.; Café, M.E.M.; Gontijo, B.; Salomão, P.R.; Pereira, L.; McGrath, J.A.

Identification of two new mutations in the TAT gene in a Danish family with tyrosinaemia type II
pp. 704-706(3)
Authors: Pasternack, S.M.; Betz, R.C.; Brandrup, F.; Gade, E.F.; Clemmensen, O.; Lund, A.M.; Christensen, E.; Bygum, A.

Wilms tumour as a possible early manifestation of hereditary leiomyomatosis and renal cell cancer?
pp. 707-709(3)
Authors: Badeloe, S.; vanSpaendonck-Zwarts, K.Y.; vanSteensel, M.A.M.; vanMarion, A.M.W.; vanEssen, A.J.; Jonkman, M.F.; Steijlen, P.M.; Poblete-Gutiérrez, P.; vanGeel, M.; Frank, J.

Stromal cell-derived factor 1 expression in various skin tumours
pp. 710-713(4)
Authors: Chen, S-J.; Nakahara, T.; Kido, M.; Takahara, M.; Uchi, H.; Takeuchi, S.; Dugu, L.; Tu, Y-T.; Moroi, Y.; Furue, M.

MUM1 expression does not differentiate primary cutaneous anaplastic large-cell lymphoma and lymphomatoid papulosis
pp. 713-713(1)
Authors: Hernandez-Machin, B.; deMisa, R.F.; Montenegro, T.; Rivero, J.C.; Bastida, J.; Febles, C.; Pique, E.

A case of primary cutaneous diffuse large B-cell lymphoma, leg type monitored with fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography
pp. 713-716(4)
Authors: Liu, M.; Shan, S.J.; Xiao, T.; Yin, Y.F.; Wu, J.; Wei, H.C.; Chen, H.D.; He, C.D.

New-onset psoriasis in a patient treated with interferon beta-1a
pp. 716-717(2)
Authors: López-Lerma, I.; Iranzo, P.; Herrero, C.

Time course for development of psoralen plus ultraviolet A erythema following oral administration of 5-methoxypsoralen
pp. 717-719(3)
Authors: Berroeta, L.; Attili, S.; Wong, A.; Man, I.; Dawe, R.S.; Ferguson, J.; Ibbotson, S.H.

Phosphodiesterase-5 inhibitors and rosacea: report of 10 cases
pp. 719-720(2)
Authors: Ioannides, D.; Lazaridou, E.; Apalla, Z.; Devliotou-Panagiotidou, D.

Every cloud has a silver lining?
pp. 722-722(1)
Author: White, J.

News and Notices
pp. 723-724(2)

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A